2017
DOI: 10.18544/pedm-23.01.0073
|View full text |Cite
|
Sign up to set email alerts
|

A follow-up history of young man with apparent cortisone reductase deficiency (ACRD) – several years after diagnosis

Abstract: Hydrocortisone treatment is ineffective in ACRD patients because it was rapidly metabolized to cortisone. We have found the balance between the dexamethasone treatment effects of adrenal suppression and the achievement of full height potential considering the condition of our patient.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2019
2019

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 18 publications
0
1
0
Order By: Relevance
“…In contrast, inhibition of adipocyte 11β-HSD1 improves visceral obesity and MS associated with a reduction in adipose H6PDH in animal obesity models [25]. Moreover, patients with target gene mutations in H6PDH have impaired cortisol production [26,27]. Taken together, these studies suggest that adipose tissue H6PDH is able to couple the regulation of cellular GC metabolism and energy homeostasis relative to MS and visceral obesity.…”
Section: Introductionmentioning
confidence: 94%
“…In contrast, inhibition of adipocyte 11β-HSD1 improves visceral obesity and MS associated with a reduction in adipose H6PDH in animal obesity models [25]. Moreover, patients with target gene mutations in H6PDH have impaired cortisol production [26,27]. Taken together, these studies suggest that adipose tissue H6PDH is able to couple the regulation of cellular GC metabolism and energy homeostasis relative to MS and visceral obesity.…”
Section: Introductionmentioning
confidence: 94%